Related Experiment Video
Updated: May 8, 2026

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
MicroRNA-130b targets Fmr1 and regulates embryonic neural progenitor cell proliferation and differentiation
Xi Gong1, Kunshan Zhang, Yanlu Wang
1State Key Laboratory of Food Science and Technology, College of Life Sciences and Food Engineering, Nanchang University, Nanchang 330047, China.
Abstract:
Fragile X syndrome, one of the most common forms of inherited mental retardation, is caused by expansion of the CGG repeat in the 5'-untranslated region of the X-linked Fmr1 gene, which results in transcriptional silencing and loss of expression of its encoded protein FMRP. The loss of FMRP increases proliferation and alters fate specification in adult neural progenitor cells (aNPCs). However, little is known about Fmr1 mRNA regulation at the transcriptional and post-transcriptional levels. In the present study, we report that miR-130b regulated Fmr1 expression by directly targeting its 3'-untranslated region (3' UTR). Up-regulation of miR-130b in mouse embryonic neural progenitor cells (eNPCs) decreased Fmr1 expression, markedly increased eNPC proliferation and altered the differentiation tendency of eNPCs, suggesting that antagonizing miR-130b may be a new therapeutic entry point for treating Fragile X syndrome.
Insights
MicroRNA-130b (miR-130b) directly targets the Fmr1 gene, impacting Fragile X syndrome. Inhibiting miR-130b may offer a new therapeutic strategy for Fragile X syndrome.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Fragile X syndrome is a common inherited intellectual disability caused by FMR1 gene CGG-repeat expansion.
- Loss of Fragile Fetal Membrane gene-1 (FMRP) protein, due to FMR1 gene silencing, affects neural progenitor cell proliferation and differentiation.
- Mechanisms of FMR1 mRNA regulation at transcriptional and post-transcriptional levels are not fully understood.
Purpose of the Study:
- To investigate the role of microRNAs in regulating FMR1 gene expression.
- To identify specific microRNAs targeting the FMR1 gene.
- To explore the potential of targeting microRNAs as a therapeutic approach for Fragile X syndrome.
Main Methods:
- Investigated miR-130b's interaction with the 3'-untranslated region (3' UTR) of the FMR1 gene.
- Utilized mouse embryonic neural progenitor cells (eNPCs) to study the effects of miR-130b.
- Assessed changes in FMR1 expression, eNPC proliferation, and differentiation upon miR-130b modulation.
Main Results:
- miR-130b directly targets the 3' UTR of the FMR1 gene.
- Up-regulation of miR-130b in eNPCs led to decreased FMR1 expression.
- Increased miR-130b levels markedly enhanced eNPC proliferation and altered their differentiation patterns.
Conclusions:
- miR-130b plays a significant role in regulating FMR1 expression.
- The miR-130b/FMR1 axis influences neural progenitor cell behavior.
- Antagonizing miR-130b presents a potential novel therapeutic strategy for Fragile X syndrome.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Master Transcription Regulators

